Skip to content
Screener

Accrued Expenses at other companies

Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$2.97B
Opus Genetics logo
Opus GeneticsIRD
$795K+54.4%
Relay Therapeutics, Inc. logo
Relay Therapeutics, Inc.RLAY
$1.25M+106%
Prime Medicine logo
Prime MedicinePRME
$3.42M-41.3%
4D Molecular Therapeutics logo
4D Molecular TherapeuticsFDMT
$22.87M+41.1%
Ginkgo Bioworks logo
Ginkgo BioworksDNA
$49.95M-12.7%

Other financials

Income statement

See full
Revenue$293.0K-84.8%
Operating income-$40.8M+1.9%
Net income-$46.3M-15.8%
EPS (diluted)-$0.57-11.8%

Balance sheet

See full
Cash & equivalents$71.5M+7.5%
Total debt$62.7M-22.5%
Total equity-$58.1M-276%
Total assets$244.7M+9.2%

Cash flow

See full
Operating cash flow$17.8M+148%
CapEx$2.0M+17.4%
Free cash flow$15.8M+141%

Valuation

See full
Market cap$1.21B+91.4%
Enterprise value$1.2B+76.4%
P/S15.1×-1.5×

Profitability

See full
Operating margin-597.9%-207pp
Net margin-615.3%
FCF margin-441.5%-126pp

Returns & leverage

See full
Return on equity-379.5%
Debt / equity27.2×+26.1×
Current ratio0.5×-1.0×

Where this comes from

Reported directly by MeiraGTx Holdings plc in its filing.

Tagged under the XBRL concept us-gaap:OtherLiabilitiesCurrent.

The source filing: MeiraGTx Holdings plc’s 10-Q, filed May 14, 2026.

Filed
May 14, 2026, 8:30 AM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001104659-26-060739
Line itemMarch 31, 2026December 31, 2025
Lease obligations - finance leases, current3938
Deferred revenue - related party, current1,9961,776
Note payable, net, current24,86624,648
Other current liabilities105,10850,283
Total Current Liabilities176,127122,555
Deferred revenue - related party64,84065,120
Lease obligations - operating leases10,61111,351
Lease obligations - finance leases97109

Item 1. Financial Statements (Unaudited)

FAQ

What is MeiraGTx Holdings plc's accrued expenses?
MeiraGTx Holdings plc (MGTX) reported accrued expenses of $105.11M in Q1 2026.
How has MeiraGTx Holdings plc's accrued expenses changed year-over-year?
MeiraGTx Holdings plc's accrued expenses increased by 18022.1% year-over-year, from $580K to $105.11M.
What is the long-term trend for MeiraGTx Holdings plc's accrued expenses?
Over 5 years (2020 to 2025), MeiraGTx Holdings plc's accrued expenses has grown at a 361.6% compound annual growth rate (CAGR), from $24K to $50.28M.
What does accrued expenses mean?
Expenses incurred but not yet paid or invoiced — interest accruals, tax accruals, warranty reserves, and other timing differences.

Ask your AI about MeiraGTx Holdings plc's accrued expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude